Cited by 498Cancer-related Molecular PathwaysPI3K/AKT/mTOR signaling in cancerCell death mechanisms and regulation

p53 and E2f: partners in life and death

Polager, Shirley, Ginsberg, Doron·2009·Nature Reviews Cancer

Abstract

During tumour development cells sustain mutations that disrupt normal mechanisms controlling proliferation. Remarkably, the Rb-E2f and MDM2-p53 pathways are both defective in most, if not all, human tumours, which underscores the crucial role of these pathways in regulating cell cycle progression and viability. A simple interpretation of the observation that both pathways are deregulated is that they function independently in the control of cell fate. However, a large body of evidence indicates that, in addition to their independent effects on cell fate, there is extensive crosstalk between these two pathways, and specifically between the transcription factors E2F1 and p53, which influences vital cellular decisions. This Review discusses the molecular mechanisms that underlie the intricate interactions between E2f and p53.

Integrity signals

Registry

Crossref · 10.1038/nrc2718

Cites

135 of 135 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

1 of the 136 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Polager, S., & Ginsberg, D.
Affiliations
Bar-Ilan University (IL)
Corresponding author
Ginsberg, Doron
Venue
Nature Reviews Cancer
Published
2009-10
Volume
9
Issue
10
Pages
738-748
ISSN
  • 1474-175X (ISSN-L)
  • 1474-1768
OpenAlex
W2019562165
Cited by
498
References
136
Citations by year
2026: 7 · 2025: 12 · 2024: 20 · 2023: 23 · 2022: 13 · 2021: 23 · 2020: 18 · 2019: 23 · 2018: 27 · 2017: 35 · 2016: 38 · 2015: 41 · 2014: 43 · 2013: 54 · 2012: 46
FWCI
3.53
Type
journal article
Language
en
Open access
closed
Locations
  • Nature reviews. Cancer (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
p53, E2F1, Rb/E2F pathway, MDM2-p53 pathway, pathway crosstalk, cell cycle regulation, cell fate, carcinogenesis, transcription factors, tumor suppressor
MeSH terms
Cell Cycle, Cell Survival, Humans, Mutation, Neoplasms, Signal Transduction, Tumor Suppressor Protein p53, Apoptosis, Cell Proliferation, E2F Transcription Factors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review